Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/25/2012CA2526338C Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
09/25/2012CA2525524C Combination of the analeptic modafinil and an antidepressant for the treatment of depression
09/25/2012CA2523188C Methods for treatment of parkinson's disease
09/25/2012CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
09/25/2012CA2517769C Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
09/25/2012CA2516822C Method for preparing acid addition salts of polyacidic basic compound
09/25/2012CA2497187C Process for preparing nitrooxyderivatives of naproxen
09/25/2012CA2496688C Glycinamide derivatives as raf-kinase inhibitors
09/25/2012CA2492846C Motilide compounds
09/25/2012CA2489427C Combination of azelastine and steroids
09/25/2012CA2478049C Humanized antibodies that recognize beta amyloid peptide
09/25/2012CA2466591C Template-fixed peptidomimetics as inhibitors of serine proteases
09/25/2012CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression
09/25/2012CA2443159C Liquid formulations for dermal application in treatment of parasitic insects in animals
09/25/2012CA2442366C Histone deacetylase inhibitors
09/25/2012CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
09/25/2012CA2369388C Plant preparation containing phenethylisothiocyanate
09/25/2012CA2229171C Method of modulating gene expression with reduced immunostimulatory response
09/25/2012CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses
09/22/2012CA2734662A1 Pharmaceutical composition containing tosufloxacin or salt thereof
09/21/2012CA2771635A1 Crystalline levofolinic acid and process for its preparation
09/20/2012WO2012126013A2 Method for making pluripotent stem cells
09/20/2012WO2012125996A2 Denture adhesive remover for intraoral and extraoral use
09/20/2012WO2012125993A1 Solid state forms of rilpivirine base, and rilipivirine salts
09/20/2012WO2012125983A1 Antiviral treatments
09/20/2012WO2012125981A2 Raf kinase inhibitors
09/20/2012WO2012125957A2 Methods and materials for reducing venous stenosis formation of an arteriovenous fistula or graft
09/20/2012WO2012125926A2 Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
09/20/2012WO2012125913A1 Methods and use of bifunctional enzyme-building clamp-shaped molecules
09/20/2012WO2012125900A1 2'-allene-substituted nucleoside derivatives
09/20/2012WO2012125893A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125887A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125886A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125884A1 Derivatives of celecoxib, use thereof and preparation thereof
09/20/2012WO2012125872A2 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
09/20/2012WO2012125871A2 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012WO2012125864A2 Overcoming resistance to erbb pathway inhibitors
09/20/2012WO2012125832A2 Antimicrobial agents
09/20/2012WO2012125830A2 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012WO2012125828A2 Methods of treating breast cancer with anthracycline therapy
09/20/2012WO2012125797A1 Nuclear hormone receptor modulators
09/20/2012WO2012125787A1 METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFβ AND RUNX1 PROTEINS
09/20/2012WO2012125772A2 Oral formulations for promoting cellular purification
09/20/2012WO2012125749A2 INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
09/20/2012WO2012125746A1 Tricyclic gyrase inhibitors
09/20/2012WO2012125663A2 Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists
09/20/2012WO2012125662A1 Indole derivatives useful as ccr2 antagonists
09/20/2012WO2012125661A1 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists
09/20/2012WO2012125629A1 Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
09/20/2012WO2012125623A2 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
09/20/2012WO2012125622A1 Substituted adipic acid amides and uses thereof
09/20/2012WO2012125614A1 Compositions and methods for the therapy and diagnosis of influenza
09/20/2012WO2012125613A1 Morpholine-spirocyclic piperidine amides as modulators of ion channels
09/20/2012WO2012125598A1 Benzodioxane inhibitors of leukotriene production
09/20/2012WO2012125567A2 Vaccine formulation of mannose coated peptide particles
09/20/2012WO2012125544A2 Necroptosis inhibitors and methods of use therefor
09/20/2012WO2012125533A1 3-benzyloxyphenyloxoacetic acid compounds for reducing uric acid
09/20/2012WO2012125524A1 Compositions and methods for the treatment of musculoskeletal related diseases and disorders using metal ion-citrate analog complexes
09/20/2012WO2012125518A1 Salt forms of 3 - cyclopropylcarbonyl - 3, 6 - diazabicyclo [3.1.1] heptane
09/20/2012WO2012125510A1 Combination therapies for hematologic malignancies
09/20/2012WO2012125486A1 Combination chemotherapy for treating cancer
09/20/2012WO2012125475A1 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2-6-dione in treatment of immune-related and inflammatory diseases
09/20/2012WO2012125459A1 Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
09/20/2012WO2012125447A2 Piperazinedione compounds
09/20/2012WO2012125438A1 Solid forms of 3-(5-amino-2methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/20/2012WO2012125413A2 Compositions for ameliorating systemic inflammation and methods for making and using them
09/20/2012WO2012125405A2 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
09/20/2012WO2012125402A2 Dosing regimens for the treatment of fabry disease
09/20/2012WO2012125359A1 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
09/20/2012WO2012125306A1 Multiantivirus compound, composition and method for treatment of virus diseases
09/20/2012WO2012125305A1 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012WO2012125071A1 1,3-diethylbenzimidazole salts - immunostimulating agents and pharmaceutical compositions on the basis thereof
09/20/2012WO2012125034A1 Method for treating neurotrauma
09/20/2012WO2012125020A1 Method for treating neurotrauma
09/20/2012WO2012125007A2 Methods and compositions for the treatment, prevention, and alleviation of bone and cartilage diseases or injuries and hair loss
09/20/2012WO2012124982A2 Oral preparation having an enteric coating
09/20/2012WO2012124973A2 Combined formulation with improved stability
09/20/2012WO2012124966A2 Fentanyl transdermal patch
09/20/2012WO2012124873A1 Pharmaceutical composition for treatment, prevention or alleviation of bone and cartilage diseases
09/20/2012WO2012124858A1 Pharmaceutical composition with enhanced efficacy for inhibiting angiogenesis
09/20/2012WO2012124825A1 Sulfonamide compounds having trpm8 antagonistic activity
09/20/2012WO2012124782A1 Condensed heterocyclic compound
09/20/2012WO2012124775A1 Nitrogen-containing saturated heterocyclic compound
09/20/2012WO2012124750A1 Azole derivative
09/20/2012WO2012124744A1 Nitrogen-containing condensed heterocyclic compound
09/20/2012WO2012124743A1 Method for producing polygonum tinctorium extract
09/20/2012WO2012124738A1 Bleomycin hydrolase production promoting agent
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012124688A1 Vector for pulmonary delivery, inducing agent, and uses
09/20/2012WO2012124649A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/20/2012WO2012124641A1 Activity enhancer for anticancer agent
09/20/2012WO2012124614A1 Agent for fostering hair and accelerating hair growth
09/20/2012WO2012124311A1 Novel phenylpyridine derivative and drug containing same
09/20/2012WO2012123958A1 Highly pure salts of clopidogrel free of genotoxic impurities
09/20/2012WO2012123952A1 Enantiomers of fluconazole analogues containing thieno-[2,3-d]pyrimidin-4(3h)-one moiety as antifungal agents
09/20/2012WO2012123945A1 Process for the preparation of a stable polymorphic form of atovaquone
09/20/2012WO2012123938A1 Quinolone analogs for treating autoimmune diseases
09/20/2012WO2012123922A1 Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
09/20/2012WO2012123889A1 A synergistic pharmaceutical combination for the treatment of pancreatic cancer
09/20/2012WO2012123858A1 Amorphous lurasidone hydrochloride
1 ... 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 ... 7860